C5orf46 and glioblastoma: By analyzing the RNA-seq data and clinical information of 169 recurrent glioblastoma (GBM) samples obtained from TCGA, Tang et al. (2021) identified C5ORF46 as one of the DEG signatures that may account for the recurrent status of GBM.